Skip to main content
OpenTrials

Clinical trial condition

Skin Neoplasms

Explore clinical trials studying Skin Neoplasms. Study availability and eligibility vary by location and protocol.

2,110 public trials 360 recruiting studies
Refine in advanced search Browse all conditions

Skin Neoplasms trial results

Active, Not Recruiting

Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies

NCT04541108

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +23 more
Locations
  • LSU Health Sciences Center - Shreveport Shreveport, Louisiana, United States
  • Montefiore Medical Center The Bronx, New York, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • UC Health Cincinnati, Ohio, United States
View Trial Details
Active, Not Recruiting

Talimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV Melanoma

NCT02965716

Conditions
Advanced Melanoma, Melanoma, Neoplasms, +17 more
Locations
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • CTCA at Western Regional Medical Center Goodyear, Arizona, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 20 locations
View Trial Details
Active, Not Recruiting

Treating Patients With Melanoma and ALK Alterations With Ensartinib

NCT03420508

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Westchester East White Plains, New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Active, Not Recruiting

National Cancer Institute "Cancer Moonshot Biobank"

NCT04314401

Conditions
Acute Myeloid Leukemia, Adnexal Diseases, Anatomic Stage III Breast Cancer AJCC v8, +98 more
Locations
  • Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis Daphne, Alabama, United States
  • Thomas Hospital Fairhope, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • Gulf Health Hospitals Inc/Infirmary Cancer Care - Saraland Saraland, Alabama, United States
View all 150 locations
View Trial Details
Active, Not Recruiting

A Study to Investigate the Antitumor Activity, Safety, Tolerability, and Pharmacokinetics of BGB-A445 in Combination With Tislelizumab in Participants With Select Advanced Solid Tumors.

NCT05661955

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +26 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • The Second Hospital and Clinical Medical School, Lanzhou University Lanzhou, Gansu, China
  • Zhujiang Hospital of Southern Medical University Guangzhou, Guangdong, China
View all 18 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate Adaptive Dosing of Ipilimumab and Nivolumab Combination Immunotherapy

NCT03122522

Conditions
Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations
  • Hartford Healthcare Alliance (Data Collection Only) Hartford, Connecticut, United States
  • Jaykumar Thumar Hartford, Connecticut, United States
  • JOHNS HOPKINS HOSPITAL (Data Analysis Only) Baltimore, Maryland, United States
  • Brigham and Women's Hospital (Data and Specimen Analysis Only) Boston, Massachusetts, United States
View all 14 locations
View Trial Details

Related conditions